Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

French validation of the questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS).

Marques A, Vidal T, Pereira B, Benchetrit E, Socha J, Pineau F, Elbaz A, Artaud F, Mangone G, You H, Cormier F, Galitstky M, Pomies E, Rascol O, Derkinderen P, Weintraub D, Corvol JC, Durif F; DIGPD study group.

Parkinsonism Relat Disord. 2019 Mar 4. pii: S1353-8020(19)30072-0. doi: 10.1016/j.parkreldis.2019.02.026. [Epub ahead of print]

PMID:
30862454
2.

Longitudinal analysis of impulse control disorders in Parkinson disease.

Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee PC, Brice A, Vidailhet M, Elbaz A; DIGPD Study Group.

Neurology. 2018 Jul 17;91(3):e189-e201. doi: 10.1212/WNL.0000000000005816. Epub 2018 Jun 20.

3.

Molecular basis of dopamine replacement therapy and its side effects in Parkinson's disease.

You H, Mariani LL, Mangone G, Le Febvre de Nailly D, Charbonnier-Beaupel F, Corvol JC.

Cell Tissue Res. 2018 Jul;373(1):111-135. doi: 10.1007/s00441-018-2813-2. Epub 2018 Mar 7. Review.

PMID:
29516217
4.

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM.

Nature. 2009 Feb 12;457(7231):882-6. doi: 10.1038/nature07684. Epub 2009 Jan 28.

Supplemental Content

Loading ...
Support Center